Incyte Corporation
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS

Abstract:

This application relates to compounds of Formula (I): ##STR00001## or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-.gamma. which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.